Rep. Marjorie Taylor Greene Buys Cardinal Health, Inc. (NYSE:CAH) Stock

Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of Cardinal Health, Inc. NYSE: CAH. In a filing disclosed on May 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Cardinal Health stock on May 5th. The trade occurred in the Representative's "MARJORIE IRA" account.

Representative Marjorie Taylor Greene also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of AbbVie NYSE: ABBV on 5/5/2025.
• Purchased $1,001 - $15,000 in shares of Occidental Petroleum NYSE: OXY on 5/5/2025.
• Purchased $1,001 - $15,000 in shares of Paychex NASDAQ: PAYX on 5/5/2025.
• Purchased $1,001 - $15,000 in shares of MercadoLibre NASDAQ: MELI on 5/5/2025.
• Purchased $1,001 - $15,000 in shares of Starbucks NASDAQ: SBUX on 5/5/2025.
• Purchased $1,001 - $15,000 in shares of BP NYSE: BP on 5/5/2025.
• Purchased $1,001 - $15,000 in shares of Gilead Sciences NASDAQ: GILD on 5/5/2025.
• Purchased $1,001 - $15,000 in shares of BHP Group NYSE: BHP on 5/5/2025.
• Purchased $1,001 - $15,000 in shares of Advanced Micro Devices NASDAQ: AMD on 5/5/2025.
• Purchased $1,001 - $15,000 in shares of Alphabet NASDAQ: GOOG on 5/5/2025.

Cardinal Health Stock Up 0.7 %

NYSE:CAH traded up $1.09 during trading hours on Friday, hitting $148.36. 3,241,366 shares of the company traded hands, compared to its average volume of 2,210,082. The company has a market cap of $35.41 billion, a PE ratio of 27.68, a PEG ratio of 1.49 and a beta of 0.66. The firm's 50-day simple moving average is $134.65 and its 200-day simple moving average is $126.30. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $154.07.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The company had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. During the same period last year, the business posted $2.08 earnings per share. Cardinal Health's revenue was up .0% on a year-over-year basis. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be paid a $0.5107 dividend. The ex-dividend date is Tuesday, July 1st. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a dividend yield of 1.38%. Cardinal Health's dividend payout ratio is 31.51%.

Hedge Funds Weigh In On Cardinal Health

Several hedge funds have recently bought and sold shares of CAH. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Cardinal Health in the first quarter worth $26,000. Cyrus J. Lawrence LLC purchased a new stake in shares of Cardinal Health in the 4th quarter valued at about $26,000. Tompkins Financial Corp boosted its position in shares of Cardinal Health by 106.7% during the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after acquiring an additional 128 shares during the last quarter. Promus Capital LLC purchased a new position in shares of Cardinal Health during the fourth quarter worth about $30,000. Finally, Bellwether Advisors LLC purchased a new position in shares of Cardinal Health during the fourth quarter worth about $32,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CAH. UBS Group increased their price target on shares of Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a research report on Tuesday, April 29th. StockNews.com upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 5th. Morgan Stanley upped their price objective on Cardinal Health from $142.00 to $166.00 and gave the company an "overweight" rating in a research note on Monday, May 5th. JPMorgan Chase & Co. raised their target price on Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Finally, Jefferies Financial Group upgraded Cardinal Health from a "hold" rating to a "buy" rating and increased their price target for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $146.43.

About Representative Greene

Marjorie Taylor Greene (Republican Party) is a member of the U.S. House, representing Georgia's 14th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027. Greene (Republican Party) is running for re-election to the U.S. House to represent Georgia's 14th Congressional District. She declared candidacy for the 2026 election.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.